Navigation Links
Biofisica Obtains $2.3 Million in Financing From Investors
Date:4/21/2008

ATLANTA, April 21 /PRNewswire/ -- Biofisica Inc., an Atlanta-based company specializing in wound care therapy, today announced that it has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica's continued marketing efforts in the UK and ongoing planning initiatives in the U.S.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070808/CLW014LOGO )

The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors.

"We are very pleased that our investors continue to show a tremendous vote of confidence for the progress that we're making with our business plan and the recognition that POSiFECT(R) serves a critical need in the wound care market," said Rafael Andino, founder of Biofisica.

POSiFECT is the first medical device available that combines two technologies - moist wound-care dressing and electrical stimulation - in a fully disposable, easy-to-use, sterile dressing that facilitates the normal healing process. Clinical research has shown that POSiFECT accelerates healing in difficult to heal or non-healing chronic wounds. The product launched last year in the UK and has since had excellent clinical response in a post market surveillance study. POSiFECT also has been approved for marketing in Canada. The product is not yet available in the U.S.

"We believe that Biofisica's POSiFECT technology represents an innovative and effective approach to the treatment of chronic wounds," said Dion Madsen, managing director of Physic Ventures, the General Partner for Unilever Technology Ventures. "Chronic wounds are currently poorly treated and this technology approach represents a very convenient and cost effective therapy that has the potential to improve the lives of millions of chronic wound care patients."

About Biofisica

Biofisica Inc., ( http://www.biofisica.com ) is a high-tech wound care company that was founded in Atlanta, Georgia (USA) to develop new solutions within the tissue engineering market to specifically address chronic wound healing. Biofisica's wound care technology is uniquely positioned to provide chronic wound solutions to the wound care market - a global market that is estimated in excess of $12 billion.

The company also has offices in the United Kingdom. Biofisica was named as one of Georgia's top 40 technology companies in 2006 by the Technology Association of Georgia.


'/>"/>
SOURCE Biofisica Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
2. Botaneco obtains $2.4 million in funding from AVAC
3. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
4. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
5. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
6. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
7. PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations
8. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
9. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
10. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
11. CrossFire Beilstein Database Exceeds Ten Million Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... ... January 12, 2017 , ... ... Vertebral Technologies, Inc., announces the successful outcome of the first lumbar fusion ... VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product company BioMedical ...
(Date:1/12/2017)... AURORA, Colo (PRWEB) , ... January 12, 2017 ... ... and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a ... eLife describes a new drug combination that has stabilized Rosendahl’s disease and increased ...
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock (Pork/Swine, Poultry, ... to 2022", published by MarketsandMarkets, the global market is estimated to be valued ... by 2022, at a CAGR of 6.96% from 2016. ... ... ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... clinics in Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand ... path of discovery. , Now, as an assistant professor of biology and biotechnology ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
Breaking Biology News(10 mins):